Literature DB >> 10079264

Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions.

I Leav1, F B Merk, K F Lee, M Loda, M Mandoki, J E McNeal, S M Ho.   

Abstract

In situ hybridization and immunohistochemistry were used to localize and compare the expression of the long form of the human prolactin receptor in fetal, prepubertal, and adult prostate. Results were then compared with hyperplastic, dysplastic, and neoplastic lesions. Both receptor message and protein were predominately localized in epithelial cells of the fetal, neonatal, prepubertal, and normal adult prostate. In hyperplastic lesions the expression of the receptor was unchanged with respect to normal epithelial cells. Irrespective of grade, markedly enhanced expression of the receptor was evident in dysplastic lesions. In lower Gleason grade carcinomas the intensity of receptor signal at the message and protein levels approximated that found in normal prostatic epithelium. However, in foci within higher grade cancers, receptor expression appeared diminished. Results from our study suggest that prolactin action plays a role in the development and maintenance of the human prostate and may also participate in early neoplastic transformation of the gland. Diminution of receptor expression in high grade neoplasms could reflect the emergence of a population of cells that are no longer responsive to the peptide hormone.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10079264      PMCID: PMC1866401          DOI: 10.1016/S0002-9440(10)65333-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  PITUITARY FACTORS INFLUENCING GROWTH OF THE PROSTATE.

Authors:  J T GRAYHACK
Journal:  Natl Cancer Inst Monogr       Date:  1963-10

2.  Characterization of the prolactin receptor in human prostate.

Authors:  A Leake; G D Chisholm; F K Habib
Journal:  J Endocrinol       Date:  1983-11       Impact factor: 4.286

Review 3.  Prolactin as an autocrine/paracrine factor in breast tissue.

Authors:  C V Clevenger; T L Plank
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

4.  Evidence for a role of prolactin in prostate and seminal vesicle growth in immature male rats.

Authors:  A Negro-Vilar; W A Saad; S M McCann
Journal:  Endocrinology       Date:  1977-03       Impact factor: 4.736

5.  Intraductal dysplasia: a premalignant lesion of the prostate.

Authors:  J E McNeal; D G Bostwick
Journal:  Hum Pathol       Date:  1986-01       Impact factor: 3.466

6.  Measurements of prolactin and androgens in patients with prostatic diseases.

Authors:  J Saroff; R Y Kirdani; T M Chu; Z Wajsman; G P Murphy
Journal:  Oncology       Date:  1980       Impact factor: 2.935

Review 7.  Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins.

Authors:  C W Welsch
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

8.  Prolactin influence on cytosol and nuclear androgen receptors in the ventral, dorsal, and lateral lobes of the rat prostate.

Authors:  G S Prins
Journal:  Endocrinology       Date:  1987-04       Impact factor: 4.736

9.  Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats.

Authors:  I Leav; S M Ho; P Ofner; F B Merk; P W Kwan; D Damassa
Journal:  J Natl Cancer Inst       Date:  1988-09-07       Impact factor: 13.506

10.  Differential effects of prolactin on rat dorsolateral prostate and R3327 prostatic tumor sublines.

Authors:  M P Johnson; S A Thompson; D M Lubaroff
Journal:  J Urol       Date:  1985-06       Impact factor: 7.450

View more
  15 in total

Review 1.  Benign prostatic hyperplasia: dietary and metabolic risk factors.

Authors:  H Nandeesha
Journal:  Int Urol Nephrol       Date:  2008-02-02       Impact factor: 2.370

2.  Biological significance of prolactin in gynecologic cancers.

Authors:  Vera V Levina; Brian Nolen; YunYun Su; Andrew K Godwin; David Fishman; Jinsong Liu; Gil Mor; Larry G Maxwell; Ronald B Herberman; Miroslaw J Szczepanski; Marta E Szajnik; Elieser Gorelik; Anna E Lokshin
Journal:  Cancer Res       Date:  2009-06-02       Impact factor: 12.701

Review 3.  Estrogens and prostate cancer: etiology, mediators, prevention, and management.

Authors:  Shuk-Mei Ho; Ming-Tsung Lee; Hung-Ming Lam; Yuet-Kin Leung
Journal:  Endocrinol Metab Clin North Am       Date:  2011-07-07       Impact factor: 4.741

4.  Effects of metoclopramide on mRNA levels of steroid 5α-reductase isozymes in prostate of adult rats.

Authors:  Pilar Sánchez; Jesús M Torres; Beatriz Castro; José F Frías; Esperanza Ortega
Journal:  J Physiol Biochem       Date:  2012-07-18       Impact factor: 4.158

5.  Research resource: estrogen-driven prolactin-mediated gene-expression networks in hormone-induced prostatic intraepithelial neoplasia.

Authors:  Neville N C Tam; Carol Y Y Szeto; Johannes M Freudenberg; Amy N Fullenkamp; Mario Medvedovic; Shuk-Mei Ho
Journal:  Mol Endocrinol       Date:  2010-09-22

Review 6.  Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients.

Authors:  S Sideris; F Aoun; C N Martinez; S Latifyan; A Awada; G Costante; T Gil
Journal:  J Endocrinol Invest       Date:  2016-01-19       Impact factor: 4.256

7.  Prolactin stimulates prostate cell proliferation by increasing endoplasmic reticulum content due to SERCA 2b over-expression.

Authors:  Alexandre Crépin; Gabriel Bidaux; Fabien Vanden-Abeele; Etienne Dewailly; Vincent Goffin; Natalia Prevarskaya; Christian Slomianny
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

Review 8.  Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.

Authors:  Eric M Jacobson; Eric R Hugo; Traci R Tuttle; Ruben Papoian; Nira Ben-Jonathan
Journal:  Trends Endocrinol Metab       Date:  2010-09-16       Impact factor: 12.015

9.  Prolactin and prolactin receptor expression in cervical intraepithelial neoplasia and cancer.

Authors:  Rafael Ascencio-Cedillo; Edgar Ivan López-Pulido; José Francisco Muñoz-Valle; Nicolás Villegas-Sepúlveda; Susana Del Toro-Arreola; Ciro Estrada-Chávez; Adrian Daneri-Navarro; Ramón Franco-Topete; Delia Pérez-Montiel; Alejandro García-Carrancá; Ana Laura Pereira-Suárez
Journal:  Pathol Oncol Res       Date:  2014-07-03       Impact factor: 3.201

10.  Increased expression of the prolactin receptor is associated with malignant laryngeal tumors.

Authors:  Luis R González-Lucano; José F Muñoz-Valle; Rafael Ascencio-Cedillo; José A Domínguez-Rosales; Gonzalo López-Rincón; Susana Del Toro-Arreola; Miriam Bueno-Topete; Adrián Daneri-Navarro; Ciro Estrada-Chávez; Ana L Pereira-Suárez
Journal:  Exp Ther Med       Date:  2012-01-30       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.